TNF inhibitors are drugs that can help reduce inflammation in people with serious inflammatory conditions, such as Crohn’s disease and rheumatoid arthritis. This type of Crohn’s disease ...

Tumour necrosis factor (TNF) inhibitors have changed the therapeutic standard of treatment for patients with rheumatoid arthritis (RA), providing substantial benefits in terms of clinical and ...

Second, it focuses on the risks, precautions and complications of the use of TNF-α inhibitors in these patients. Both animal and human studies concerning the role of TNF-α in IMIDs have led to ...

Psoriasis was less likely to progress to psoriatic arthritis (PsA) among patients treated with interleukin-17 (IL-17) or ...

health system who started TNF inhibitors compared with 237 otherwise similar patients treated with other "advanced" drug types, according to Bryant England, MD, PhD, of the University of Nebraska ...

Do newer types of biologics increase the risk of ... In this study, biologics, which included tumor necrosis factor (TNF) inhibitors and inhibitors of interleukin-17 (IL-17), interleukin-12/ ...

Exposure to TNF inhibitors was linked to a reduced risk for cardiovascular events among patients with AS; the impact of IL-17 inhibitors was less clear.

Treatment with TNF inhibitors yielded no differences in outcomes vs. other antirheumatic therapies among U.S. veterans with rheumatoid arthritis-associated interstitial lung disease, according to data ...

No significant difference in the risk for MACE was observed between patients with IBD receiving JAK vs TNF inhibitors.

DelveInsight’s, “HDAC Inhibitor Pipeline Insight” report provides comprehensive insights about 40+ companies and 50+ pipeline ...